Related Experiment Video
Updated: Aug 7, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
miR-30b protects nigrostriatal dopaminergic neurons from MPP(+)-induced neurotoxicity via SNCA
Yu-Fei Shen1, Zhuo-Ying Zhu1, Shu-Xia Qian1
1Institute of Neurology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China.
Objective:
To explore the function of miR-30b in pathogenesis of Parkinson's disease (PD) and its underlying molecular mechanism.
Materials And Methods:
We used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPP(+)) as a tool for constructing the PD cell model, using miR-30b mimics or inhibitors to manipulate miR-30b level for an experimental model of acquisition. The cell viability of SH-SY5Y was detected by CCK, and luciferase was used to screen the binding of target genes. The protein levels of SNCA were measured by Western blot. Then, we investigate the changes in pro- and anti-apoptotic markers with or without miR-30b treatment.
Results:
There was a significant low expression of MiR-30b in MPP(+)-induced cells. SH-SY5Y cell viability was rescued by MiR-30b overexpression. Luciferase experiments showed that MiR-30b may bind to the 3'-UTR side of SNCA and inhibited its expression. By Western blot, the SNCA level was markedly decreased by miR-30b. miR-30b attenuated the upregulation of Bax and the depletion of Bcl-2 induced by MPP(+).
Insights
MicroRNA-30b (miR-30b) is downregulated in Parkinson's disease (PD) models. Restoring miR-30b levels protects against neurotoxicity by inhibiting SNCA expression and modulating apoptosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder.
- The precise molecular mechanisms underlying PD pathogenesis are not fully understood.
- MicroRNAs (miRNAs) play crucial roles in regulating gene expression and are implicated in various diseases, including PD.
Purpose of the Study:
- To investigate the role of miR-30b in the pathogenesis of Parkinson's disease.
- To elucidate the molecular mechanisms by which miR-30b influences PD-related cellular processes.
Main Methods:
- A cellular model of Parkinson's disease was established using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPP(+)).
- miR-30b levels were manipulated using mimics and inhibitors in SH-SY5Y cells.
- Cell viability was assessed using CCK assays.
- Luciferase reporter assays were employed to identify direct targets of miR-30b.
- Western blotting was used to measure protein levels of SNCA, Bax, and Bcl-2.
Main Results:
- MPP(+) treatment led to a significant downregulation of miR-30b expression.
- Overexpression of miR-30b rescued SH-SY5Y cell viability.
- Luciferase assays indicated that miR-30b directly targets the 3'-UTR of SNCA, inhibiting its expression.
- miR-30b reduced SNCA protein levels and attenuated MPP(+)-induced upregulation of Bax and downregulation of Bcl-2.
Conclusions:
- miR-30b plays a protective role in a cellular model of Parkinson's disease.
- miR-30b exerts its neuroprotective effects by inhibiting SNCA expression and modulating apoptotic markers.
- These findings suggest that miR-30b may be a potential therapeutic target for Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology